As of 2024-12-13, the Relative Valuation of Nanobiotix SA (NANO.PA) is (9.41) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 3.29 EUR, the upside of Nanobiotix SA based on Relative Valuation is -386.2%.
The range of the Relative Valuation is (10.44) - (11.30) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 15.9x | 15.3x |
| Forward P/E multiples | 5.1x - 17.3x | 11.2x |
| Fair Price | (10.44) - (11.30) | (9.41) |
| Upside | -417.5% - -443.4% | -386.2% |
| Date | P/E |
| 2024-12-06 | -4.35 |
| 2024-12-05 | -3.94 |
| 2024-12-04 | -3.93 |
| 2024-12-03 | -3.81 |
| 2024-12-02 | -3.96 |
| 2024-11-29 | -4.19 |
| 2024-11-28 | -4.17 |
| 2024-11-27 | -4.36 |
| 2024-11-26 | -4.53 |
| 2024-11-25 | -4.69 |
| 2024-11-22 | -4.93 |
| 2024-11-21 | -5.01 |
| 2024-11-20 | -5.04 |
| 2024-11-19 | -5.07 |
| 2024-11-18 | -5.18 |
| 2024-11-15 | -5.17 |
| 2024-11-14 | -5.49 |
| 2024-11-13 | -5.26 |
| 2024-11-12 | -5.33 |
| 2024-11-11 | -5.56 |
| 2024-11-08 | -5.56 |
| 2024-11-07 | -5.53 |
| 2024-11-06 | -5.45 |
| 2024-11-05 | -5.51 |
| 2024-11-04 | -5.59 |
| 2024-11-01 | -5.58 |
| 2024-10-31 | -5.55 |
| 2024-10-30 | -5.57 |
| 2024-10-29 | -5.86 |
| 2024-10-28 | -5.91 |
| 2024-10-25 | -5.85 |
| 2024-10-24 | -6.15 |
| 2024-10-23 | -6.30 |
| 2024-10-22 | -6.42 |
| 2024-10-21 | -6.35 |
| 2024-10-18 | -6.31 |
| 2024-10-17 | -6.22 |
| 2024-10-16 | -6.12 |
| 2024-10-15 | -6.17 |
| 2024-10-14 | -6.19 |
| 2024-10-11 | -6.22 |
| 2024-10-10 | -6.26 |
| 2024-10-09 | -6.29 |
| 2024-10-08 | -6.33 |
| 2024-10-07 | -6.36 |
| 2024-10-04 | -6.58 |
| 2024-10-03 | -6.45 |
| 2024-10-02 | -6.37 |
| 2024-10-01 | -6.55 |
| 2024-09-30 | -6.99 |